Notfalltherapie der akuten herzinsuffizienz

Deutsche Medizinische Wochenschrift

Volumn 124, Issue 38 SUPPL. 2, 1999, Pages

  Werdan, Karl ^a,b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMRINONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; DOPEXAMINE; ENOXIMONE; FUROSEMIDE; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; METOLAZONE; MILRINONE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHOSPHODIESTERASE INHIBITOR; SPIRONOLACTONE; STREPTOKINASE; THIAZIDE DIURETIC AGENT;

ACUTE HEART FAILURE; CARDIOGENIC SHOCK; CLINICAL PROTOCOL; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG MECHANISM; EMERGENCY TREATMENT; HEART VENTRICLE FUNCTION; HEMODYNAMIC MONITORING; HUMAN; HYPOVOLEMIA; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; REVIEW; SUBLINGUAL DRUG ADMINISTRATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; AGED; ANALGESICS, OPIOID; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN I; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC GLYCOSIDES; DEFIBRILLATORS, IMPLANTABLE; DIURETICS; EMERGENCIES; FUROSEMIDE; HEART FAILURE, CONGESTIVE; HUMANS; MORPHINE; MYOCARDIAL INFARCTION; NITRATES; NITROGLYCERIN; PACEMAKER, ARTIFICIAL; PROGNOSIS; PULMONARY EDEMA; RECEPTORS, ANGIOTENSIN; RESPIRATION, ARTIFICIAL; RISK FACTORS; SHOCK, CARDIOGENIC; TIME FACTORS; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 0033600717     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Alpert, J. S., R. C. Becker: Mechanism and management of cardiogenic shock. Crit. Care Clin. 9 (1993), 205-218.
2. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure): Guidelines for the Evaluation and Management of Heart Failure. Circulation 92 (1995), 2764-2784.
3. Anderson, R. D., E. M. Ohman, D. R. Holmes, J. Col, A. L. Stebbins, E. R. Bates. R. J. Stomel, C. B. Granger, E. J. Topol, R. M. Califf, for the GUSTO-I Investigators: Use of intraaortic ballon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I study. J. Amer. Coll. Card. 30 (1997), 708-715.
4. Antoniucci, D., R. Valenti, G. M. Santoro, L. Bolognese, M. Trapani, G. Moschi, P. F. Fazzini: Systematic Direct Angioplasty and Stent-Supported Direct Angioplasty Therapy for Cardiogenic Shock Complicating Acute Myocardial Infarction. J. Am. Coll. Card. 31 (1998), 294.
5. Baker, D. W., R. F. Wright: Management of heart failure IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction. JAMA 272 (1994), 1614-1618.
6. Barrington, W. W., J. R. Windle, A. R. Easley, R. Rundlett, G. Eisenger: Clinical comparison of acute single to dual chamber pacing in chronically incompetent patients with left ventricular dysfunction. PACE 18 (1995), 433-440.
7. Barry, W. L., I. J. Sarembock: Cardiogenic Shock: Therapy and Prevention. Clin. Cardiol, 21 (1998), 72-80.
8. Bates, E. R., E. J. Topol: Limitations of Thrombolytic Therapy for Acute Myocardial Infarction Complicated by Congestive Heart Failure and Cardiogenic Shock. J. Amer. Coll. Cardiol. 18 (1991), 1077-1084.
9. Baumert, J.-H., R. Roissant: Mechanische Kreislaufunterstützung in der kardiochirurgischen Intensivmedizin. Intensivmed. 35 (1998) 565-573.
10. Berger, P. B., D. R. Holmes, Jr., A. L. Stebbins, E. R. Bates, R. M. Califf, E. J. Topol, for the GUSTO-1 Investigators: Impact of an Aggressive Invasive Catheterization and Revascularization Strategy on Mortality in Patients with Cardiogenic Shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) Trial - An Observational Study. Circulation 96 (1997), 122-127.
11. Berger, P. B., R. H. Tuttle, D. R. Holmes, E. J. Topol, P. E. Aylward, J. H. Horgan, R. M. Califf, for the GUSTO-I Investigators: One-Year Survival Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock, and its Relation to Early Revascularization - Results from the GUSTO-I Trial. Circulation 99 (1999), 873-878.
12. Bertel, O. E. Straumann, N. Balmelli, B. Nägeli: Der kardiogene Schock. Schweiz. Med. Wschr. 128 (1998), 1428-1435.
13. Blitz, A., H. Laks: The role of coronary revascularization in the management of heart failure: identification of candidates and review of results. Current Opin. Cardiol. 11 (1996), 276-290.
14. Bocchi, E. A., G. Belotti, A. V. deMoraes, F. Bacal, L. F. Moreira, A. Esteves-Filho, J. T. Fukushima, G. Giumaraes, N. Stolf, A. Jatene: Clinical outcome after left ventricular surgical remodeling in patients with idiopathic dilated cardiomyopathy referred for heart transplantation. Short-term results. Circulation 96 (suppl. II) (1997) II165-II175.
15. Boldt, J., C. Knothe, B. Zickmann, et al.: Phosphodiesterase-inhibitors enoximone and piroximone in cardiac surgery: influence on platelet count and function. Intens. Care Med. 18 (1992), 449-454.
16. Bolling, S. F., G. M. Deeb, L. A. Brunsing, D. S. Bach: Early outcome of mitral valve reconstruction in patients with end-stage cardiomyo-pathy. J. thorac. cardiovasc. Surg. 109 (1995), 676-682.
17. Booker, P. D., C. Evans, R. Franks: Comparison of the haemodynamic effects of dopamine and dobutamine in young children undergoing cardiac surgey. Brit. J. Anaesth. 40 (1995), 419-423.
18. Bowers, T. R., W. W. O'Neill, C. Grines, M. C. Pica, R. D. Safian, J. A. Goldstein: Effect of reperfusion on biventricular function and survival after right ventricular infarction. New Engl. J. Med. 338 (1998), 933-940.
19. Busch, I., K. Werdan: Lungenödem. In: Madler, C., K.-W. Jauch, K. Werdan (Hrsg) Das NAW-Buch - Praktische Notfallmedizin (Urban & Schwarzenberg, München 1999), S. 441-452.
20. Califf, R. M., J. R. Bengtson: Cardiogenic shock. New Engl. J. Med. 330 (1994), 1724-1730.
21. Channer, K. S., K. A. McLean, P. Lawson-Matthew, M. Richardson: Combination diuretic treatment in severe heart failure: a randomised controlled trial. Brit. Heart J. 71 (1994), 146-150.
22. Cleland, J. G. F., C. J. Bulpitt, R. H. Falk: Is aspirin safe for patients with heart failure? Brit. Heart J. 74 (1995), 215-219.
23. Cotter, G., E. Metzkor, E. Kaluski, Z. Faigenberg, R. Miller, A. Simovitz, D. Shaham, O. Marghitay, M. Koren, A. Blatt, Y. Moshkovitz, R. Zaidenstein, A. Golik: Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 351 (1998), 389-393.
24. Cowley A. J., A. M. Skene: Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators. Brit. Heart J. 72 (1994), 226-230.
25. Cuthbertson, B. H., P. Dellinger, O. J. Dyar, et al.: UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. Intens. Care Med. 23 (1997), 1212-1218.
26. Deutsche Gesellschaft für Kardiologie - Herz- und Kreislaufforschung, bearbeitet von Erbel, R., H. J. Engel, W. Kubier, T. Meinertz, K. L. Neuhaus, G. Sauer, B. E. Strauer, T. Bonzel, K. Ewen: Richtlinien der interventionellen Koronartherapie. Z. Kardiol. 86 (1997), 1040-1063.
27. Deutsche Gesellschaft für Kardiologie - Herz- und Kreislaufforschung, bearbeitet von U. C. Hoppe, E. Erdmann: Leitlinien zur Therapie der chronischen Herzinsuffizienz. Z. Kardiol 87 (1998), 645-661.
28. Döbel, K.-U., H. Buscher, H. C. Ludwig, H. Burchardi: Die Behandlung einer akuten Linksherzinsuffizienz bei Subarachnoidalblutung mit Phsophodiesterasehemmern. Intensivmed. 36 (1999), 300-303.
29. Dormans, T.P.J., J. J. M. Van Meyel, P. G. G. Gerlag, Y. Tan, F. G. M. Russel, P. Smits: Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J. Amer. Coll. Cardiol. 28 (1996), 376-382.
30. Doval, H. C., D. R. Nul, H. O. Grancelli, S. V. Perone, G. R. Bortman, R. Curiel, for GESICA: Randomized trial of low-dose amiodarone in severe congestive heart failure. Lancet 344 (1994), 493-498.
31. Dunkman, W. B., G. R. Johnson, P. E. Carson, G. Bhat, L. Farell, J. N. Cohn: Incidence of thromboembolic events in congestive heart failure. The V-HeFT Va Cooperative Studies Group. Circulation 87 (Suppl. IV) (1993), 94-101.
32. Fowler, M. B., E. L. Alderman, S. N. Oesterle, et al.: Dobutamine and dopamine after cardiac surgery: greater augmentation of myocardial blood flow with dobutamine. Circulation 70 (1984), 1103-1111.
33. Fruhwald, F. M., N. Watzinger, W. Klein: Aktuelle Therapie der akuten schweren Herzinsuffizienz. Intensivmed. 35 (1998), 543-547.
34. Garg, R. K., M. Gheorgiade, S. M. Jafri: Antiplatelet and Anticoagulant Therapy in the Prevention of Thromboemboli in Chronic Heart Failure. Progr. cardiovasc. Dis. 41 (1998), 225-236.
35. Genoni, M., L. von Segesser, U. Niederhäuser, P. Vogt, R. Jenni, O. Bertel, M. Turina: Herzchirurgie beim akuten Herzinfarkt. Indikationen und Resultate. Schweiz. Med. Wschr. 126 (1996), 682-687.
36. Gheorgiade, M., D. Benatar, M. A. Konstam, C A. Stoukides, R. O. Bonow: Pharmacotherapy for Systolic Dysfunction: A Review of Randomized Clinical Trials. Amer. J. Cadiol. 80 (1997). 14H-27H.
37. Gorscan III, J., A. M. Feldman, R. L. Kormos, W. A. Mandarine, A. J. Demetris, R. J. V. Batista: Heterogenous immediate effects of partial left ventriculectomy on cardiac performance. Circulation 97 (1998), 839.
38. Gosselink, A. T. M., H. J. G. M. Crijns, I. C. vanGelder, H. Hillige, A. C. P. Wiesfeld, K. I. Lie: Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. J. Amer. med. Assoc. 267 (1992), 3289-3293.
39. Hands, M. E., J. D. Rutherford, J. E. Muller, G. Davies, P. H. Stone, C. Parker, E. Braunwald, and the MILIS study group: The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. J. Amer. Coll. Cardiol. 14 (1989), 40-46.
40. Haque, W. A., J. Boehmer, B. S. Clemson, U. S. Leuenberger, D. H. Silber, L. I. Sinoway: Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J. Amer. Coll. Cardiol. 27 (1996), 353-358.
41. Hardy, J. F., N. Searle, M. Roy, et al.: Amrinone, in combination mit norepinephrine, is an effective first-line drug for difficult separation from cardiopulmonary bypass. Canad. J. Anaesth. 40 (1993), 495-501.
42. Hochman, J. S., J. Boland, L. A. Sleeper, M. Orway, J. Brinker, J. Col, A. Jacobs, J. Slater, D. Miller, H. Wasserman, M. A. Menegus, J. D. Talley, S. McKinlay, T. Sanborn, T. LeJemtel, and the SHOCK Registry Investigators: Current Spectrum of Cardiogenic Shock and Effect of Early Revascularization on Mortality - Results of an International Registry. Circulation 91 (1995), 873-881.
43. Hunziker, P., M. Pfisterer: Die schwere Herzinsuffizienz als medizinischer Notfall. Praxis 86 (1997), 189-195.
44. Janssens, U., P. Hanrath: Schock. Internist 35 (1994), 673-689.
45. Juste, R. N., K. Panikkar, N. Soni: The effects of low-dose dopamine infusions on haemodynamic and renal parameters in patients with septic shock requiring treatment with noradrenaline. Intens. Care Med. 24 (1998), 564-568.
46. Kasper, W.: Aktueller Stand der Thrombolyse bei akuter Lungenembolie unter besonderer Berücksichtigung der hämodynamischen Beeinträchtigung. Intensiv- u. Notfallbehandlung 23 (1998), 206-209.
47. Kato, S., S.-I. Morimoto, S. Hiramitsu, M. Nomura, T. Ito, H. Hishida: Use of Percutaneous Cardiopulmonary Support of Patients With Fulminant Myocarditis and Cardiogenic Shock for Improving Prognosis. Am J. Cardiol. 83 (1999), 623-625.
48. Kikura, M., M. K. Lee, R. A. Safon, et al.: The effects of milrinone on platelets in patients undergoing cardiac surgery. Anesth. Analg. 81 (1995), 44-48.
49. Koslowski B., W. Heit: Kardiale Probleme des Tumorpatienten - Schicksal oder Herausforderung? Intensiv- u. Notfallbehandlung 23 (1998), 54-72.
50. Kovack P. J., M. A. Rasak, E. R. Bates, E. M. Ohman, R. J. Stomel: Thrombolysis Plus Aortic Counterpulsation: Improved Survival in Patients Who Present to Community Hospitals With Cardiogenic Shock. J. Amer. Coll. Cardiol. 29 (1997), 1454-1458.
51. Leier, C. V., P. F. Binkley: Parenteral Inotropic Support for Advanced Congestive Heart Failure. Progr. cardiovasc. Dis. 41 (1998), 207-224.
52. Lema, G., J. Urzua, R. Jalil, et al.: Renal protection in patients undergoing cardiopulmonary bypass with preoperative abnormal renal function [see Comments]. Anesth. Analg. 86 (1998), 3-8.
53. Lindenfeld, J. A.: Safety and Effectiveness of Inhaled Nitric Oxide and Tirofiban for Acute Coronary Syndromes - A Report from the Cardiovascular and Renal Advisory Panel of the Food and Drug Administration. Circulation 98 (1998), 1829-1830.
54. Massie, B. M. S. G. Fisher, P. C. Deedwania, B. N. Singh, R. D. Flechter, S. N. Singh, for the CHF-STAT Investigators. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. Circulation 93 (1996), 2128-2134.
55. Müller, J., G. Wallukat, Y.-G. Wenig et al.: Weaning From Mechanical Cardiac Support in Patients With Idiopathic Dilated Cardiomyopathy. Circulation 96 (1997), 542-549.
56. Philbin, E. F., M. Cotto, T. A. Rocco, P. L. Jenkins: Association Between Diuretic Use, Clinical Response, and Death in Acute Heart Failure. Amer. J. Cardiol. 80 (1997), 519-522.
57. Piccione, W.: Mechanical circulatory assistance: changing indications and options. J. Heart Lung Transplant. 16 (1997), 25-28.
58. Redling F, I. Neumann, H.-R. Zerkowski: Herzverletzungen. Intensiv-u. Notfallbehandlung 23 (1998), 85-95.
59. Royster, R. L., J. F. T. Butterworth, R. C. Prielipp, et al.: Combined inotropic effects of amrinone and epinephrine after cardiopulmonary by-pass in humans. Anesth. Analg. 77 (1993), 662-672.
60. Ruzumna, P., M. Gheorgiade, R. O. Bonow: Mechanisms and management of heart failure due to diastolic dysfunction. Current Opin. Cardiol. 11 (1996), 169-175.
61. Schmidt, W., M. Nottrott, H. Desel: Lebensbedrohliche akute Intoxikationen durch kardio- und vasotoxisch wirkende Medikamente und Drogen. Intensiv- u. Notfallbehandlung 23 (1998), 27-49.
62. Schuster, H. P., F P. Schuster, P. Ritschel, S. Wilts, K. F. Bodmann: The ability of the Simplified Acute Physiology Score (SAPS II) to predict outcome in coronary care patients. Intens. Care Med. 23 (1997), 1056.
63. Seino Y., S.-I. Momomura, T. Takano, H. Hayakawa, K. Katoh, for the Japan Intravenous Milrinone Investigators: Multicenter, double-blind study of intravenous milrinone for patients with acute heart failure. Crit. Care Med. 24 (1996), 1490-1497.
64. Steimle, A. E., L. W. Stevenson, C. Chelimsky-Fallick, G. C. Fonarow, M. A. Hamilton, J. D. Moriguchi, A. Kartashov, J. H. Tillisch: Sustained Hemodynamic Efficacy of Therapy Tailored to Reduce Filling Pressures in Survivors With Advanced Heart Failure. Circulation 96 (1997), 1165-1172.
65. Stevenson, W. G., M. O. Sweeney: Pharmacologic and nonpharmacologic treatment of ventricular arrhythmias in heart failure. Current Opin. Cardiol. 12 (1997), 242-250.
66. Stewart. S., S. Pearson, J. D. Horowitz: Effects of a Home-Based Intervention Among Patients With Congestive Heart Failure Discharged From Acute Hospital Care. Arch intern. Med. 158 (1998), 1067-1072.
67. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine: Guidelines for intensive care unit admission, discharge and triage. Crit. Care Med. 27 (1999), 633-638.
68. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. New Engl. J. Med. 337 (1997), 1576-1583.
69. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology: Acute myocardial infarction: pre-hospital and in-hospital management. Europ. Heart J. 17 (1996), 43.
70. The Task Force of the Working Group on Heart Failure of the European Society of Cardiology: The treatment of heart failure. Europ. Heart J. 18 (1997), 736-753.
71. Tohmo, H., M. Karanko, K. Korpilahti: Haemodynamic effects of enalaprilat and preload in acute severe heart failure complicating myocardial infarction. Europ. Heart J. 15 (1994), 523-527.
72. Tohmo, H., M. Karanko, K. Korpilahti, M. Scheinin, O. Viinamaki, P. Neuvonen: Enalaprilat in acute intractable heart failure after myocardial infarction: A prospective, consecutive sample, before-after trial. Crit. Care Med. 22 (1994), 965-973.
73. Tommaso, C. L: Current Status of Percutaneously Inserted Cardiopulmonary Bypass in the Cardiac Catheterization Laboratory. Catheter. Cardiovasc. Diagn. 450 (1998), 120-121.
74. von Spiegel, T.: Monitoring des kardiovaskulären Systems. Intensiv- u. Notfallbehandlung 24 (1999), 25-32.
75. Welte T.: Akute Luftnot. Internist 39 (1998), 152-160.
76. Werdan K.: Rhythmusstabilisierung. In: Madler, C., K.-W. Jauch, K. Werdan (Hrsg) Das NAW-Buch - Praktische Notfallmedizin (Urban & Schwarzenberg, München 1999), S. 249-262).
77. Werdan, K.: Akute Koronarsyndrome: Herzinfarkt und instabileAngina pectoris.. In: Madler, C., K.-W. Jauch, K. Werdan (Hrsg) Das NAW-Buch - Praktische Notfallmedizin (Urban & Schwarzenberg, München 1999), S. 385-439).
78. Werdan, K., U. Müller-Werdan: Schock, Kollaps und akute Kreislaufinsuffizienz. In: Erdmann, E., G. Riecker (Hrsg.): Klinische Kardiologie - Krankheiten des Herzens, des Kreislaufs und der Gefäße (Springer: Berlin 1996), S. 647-736).
79. Witthaut, R., K. Werdan, H.-P. Schuster: Multiorgandysfunktions-Syndrom und Multiorganversagen - Diagnose, Prognose und Therapiekonzepte. Internist 39 (1998), 493-501.
80. Wollert K C., H. Drexler: Kardiogener Schock nach Myokardinfarkt - Aktuelle Therapieansätze. Intensivmed. 35 (1998), 535-542.